
|Videos|October 31, 2015
How the FDA Views Compounding
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
Advertisement
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
This video was recorded at the 2015 NCPA Annual Convention.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sonrotoclax Plus Zanubrutinib Produces Deep MRD Responses in Treatment-Naive CLL
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
"I Didn't Do This to Myself": How Mary Katherine Cheeley Uses Lp(a) Education to Transform Patient Adherence
4
Managing Grade 1 CRS in Patients With Follicular Lymphoma on Bispecific Antibodies: Home vs Health Care Facility Referred
5































































































































